Latest Health News

Shaver Shop Group Limited reported steady sales of $219 million for FY25, with a notable 2.1% rise in gross profit driven by its private brand Transform-U. The company’s strategic focus on exclusive products and store network optimization sets a positive tone for 2026.

Artrya Limited has expanded its SAPPHIRE clinical study with Ascension, one of the largest US non-profit health systems, joining as the fourth major participant. This move strengthens the study’s reach and advances the evaluation of Artrya’s AI-powered Salix platform for coronary artery disease detection.

AF Legal Group has reported a record-breaking first quarter for FY26, with revenue soaring 43% year-on-year and profits more than doubling. This strong start reflects strategic growth in legal talent and practice areas ahead of their upcoming AGM.

Orezone Gold Corporation reported solid Q3 and nine-month 2025 results from its Bomboré gold mine, with production slightly down but revenue boosted by higher gold prices. The company’s hard rock expansion is on track for first gold in December 2025, supporting its 2025 production guidance.

Unith Ltd has secured new contracts and expanded its strategic partnerships while advancing its ISO 27001 certification, signaling strong momentum in its AI digital human technology business.

Orica Limited reported a 6% increase in revenue to AUD 8.14 billion and a 23% rise in EBIT to AUD 992.2 million for FY2025, alongside record safety performance and significant strides in decarbonisation.

The FDA's removal of the black box warning on hormone replacement therapies marks a pivotal shift for Mayne Pharma, potentially unlocking new market opportunities and reshaping women’s health treatment.

BPH Global Ltd is pioneering a novel seaweed-based natural formulation targeting male vitality, staking a first-mover claim in this emerging segment of men’s health. The company’s R&D, led by Gaia Mariculture, aims to launch an OTC supplement with potential for clinical validation.

Proteomics International Laboratories has secured a $2.2 million Australian Government R&D tax rebate, reinforcing its financial position as it advances a promising pipeline of diagnostic tests based on its proprietary Promarker® technology.

Pathkey.AI has teamed up with Armstrong Clinical to blend AI-driven trial predictions with expert clinical strategy, aiming to boost early-phase trial success and accelerate drug development in Australia and beyond.

SHAPE Australia has agreed to acquire Arden Group, expanding its footprint in retail fitout and facilities maintenance with an earnings accretive deal.

Control Bionics has integrated Apple’s Brain-Computer Interface protocol into its NeuroNode products, promising simpler setup and enhanced communication for users with severe impairments.